Wealthspire Advisors (New York)’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$753K Sell
30,583
-241
-0.8% -$5.57K ﹤0.01% 645
2026
Q1
$738K Buy
+30,824
New +$753K 0.01% 472
2025
Q4
Sell
-917
Closed -$18.5K 1558
2025
Q3
$18.5K Buy
+917
New +$15.4K ﹤0.01% 1720

Other funds holding ELAN

Wealthspire Advisors (New York)'s ELAN Position: Q2 2026 in Review

Wealthspire Advisors (New York) reduced its Elanco Animal Health (ELAN) stake by 0.78% in Q2 2026, selling an estimated $5.57K and leaving 30,583 shares worth $753K. The position accounts for ﹤0.01% of the portfolio, ranked #645.

Wealthspire Advisors (New York) first reported a position in ELAN in Q3 2025 and has held it in 3 quarters since. 308 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Wealthspire Advisors (New York) held 30,583 shares of Elanco Animal Health worth $753K as of Q2 2026.
  • Wealthspire Advisors (New York) sold 241 Elanco Animal Health shares in Q2 2026, an estimated $5.57K.
  • Elanco Animal Health made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q2 2026, its #645 holding.
  • Wealthspire Advisors (New York) first reported a position in Elanco Animal Health in Q3 2025 and has held it in 3 quarters since.
  • 308 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q2 2026, filed 11 Aug 2026.